The FDA just voted to approve a different Covid vaccine; this one based on one of the Omicron subvariants. But the decision was anything but simple. A look at the science. Somehow we pulled it off.

Research reveals a sharp decline in both the effectiveness and duration of protection from prior infection post-Omicron, underscoring the need for updated vaccines to sustain immunity Study: ...

FRANKFURT (Reuters) - German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron ...

DeepCore-X is engineered to meet the demands of researchers working on semiconductors, energy materials, advanced coatings, and interface devices. Its key features include: Synchrotron-like ...

The dominant variant of the coronavirus has proved to be not only staggeringly infectious, but an evolutionary marvel. By Carl Zimmer By November 2021, nearly two years after the coronavirus emerged ...